Medplus Health Services opened at ₹627.60, in line with its previous close of ₹627.60. During today's session, the stock has traded between ₹612.65 and ₹627.60, with an average traded price of ₹618.23. It is currently showing a downward intraday trend.
An investment of ₹10,000 made 5 years ago in Medplus Health Services is now worth
₹ 5,503.00
resulting in a loss of
₹ 4,497.00 (44.97%)
Note: Past profits do not guarantee future returns.
No analyst rating data available.
Today's Change
-10.60 (-1.69%)
Day High
₹627.60
Day Low
₹612.65
Day Open
₹627.60
Prev Close
₹627.60
Volume
49,086
Value Traded
₹3.03 Cr
1W Return
-4.25%
1M Return
-6.54%
3M Return
-25.31%
6M Return
-28.82%
1Y Return
-21.32%
Market Cap (₹ Cr.)
7,412
PE Ratio
35.80
PB Ratio
3.81
Dividend Yield
-
ROE
11.12%
ROCE
12.20%
Book Value (₹)
164.43
Face Value (₹)
2.00
EPS (TTM)
2.76
Industry PE
-
Beta
-
Debt to Equity
-
1 Week
-4.25%
6 Week
-
1 Month
-6.54%
3 Month
-25.31%
9 Month
-27.09%
Medplus promoter Agilemed pledges 5.5 lakh shares to maintain security cover
Agilemed Investments pledged 5,50,000 shares on September 30, 2026, to maintain security cover for existing NCDs. Total promoter group encumbrance rose to 74.10% of their combined shareholding following the new pledge. No fresh borrowing occurred; the pledge secures existing debt facilities held by Modulus Alternatives and Neo funds. Encumbered shares now constitute 29.79% of Medplus Health Services' total share capital.
6 days agoMedplus board cites interpretational difference in SEBI LODR non-compliance
Medplus board cited interpretational difference for SEBI LODR non-compliance. Fine levied for appointing independent director over 75 years old. Shareholders approved appointment via special resolution on August 17, 2026. Management directed to strengthen governance processes.
1mo agoMedPlus acquires final 0.01% stake in Optival Health for ₹1.10 crore
MedPlus board approves acquisition of remaining 0.01% stake in Optival Health Solutions. Cash consideration is ₹1.10 crore for 17,986 equity shares. Optival becomes a wholly owned subsidiary of MedPlus. Optival reported FY26 turnover of ₹6,816.44 crore. Transaction is not classified as a related party deal.
1mo agoAgilemed pledges 5 lakh more Medplus shares to restore cover
Agilemed Investments pledged 5,00,000 additional Medplus shares on August 19, 2026. Total encumbered stake by Agilemed rises to 1,28,77,525 shares (10.72%). Pledge created to restore Security Cover Ratio per top-up notice from trustee. Catalyst Trusteeship Limited acts as Debenture Trustee for Neo Asset Management.
1mo agoMedplus Health Services holds 20th AGM, approves FY26 results
Medplus Health Services Limited completed its 20th AGM on August 17, 2026, approving FY26 financials and re-keying its leadership team. The unqualified audit opinions and smooth passage of director appointments signal stable corporate governance for the pharmacy chain.
1mo agoMedPlus Health Services Records ₹60.69 Crore Block Trade on BSE
MedPlus Health Services recorded a block trade on the BSE worth ₹60.69 crore, involving approximately 869419 shares at ₹698.00 per share. The transaction represents a significant single-session large-lot deal on the exchange. Such block trades are typically associated with institutional-level participation and bulk share transfers.
2mo ago| Stock | LTP | Change % | Market Cap (Cr.) | PE | 1Y Return |
|---|---|---|---|---|---|
| ₹1,614.20 | -1.82% | ₹7,025.49 | 42.70 | +43.74% | |
| ₹83.75 | +0.90% | ₹163.55 | 32.42 | +102.05% |
An investment of ₹10,000 made 5 years ago in Medplus Health Services is now worth
₹ 5,503.00
resulting in a loss of
₹ 4,497.00 (44.97%)
Note: Past profits do not guarantee future returns.
